Faculty

Institution

Unit

Venue

Lisly Chery

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Palliative, Rehabilitation And Integrative Medicine

Department Of Neurosurgery

Division Of Surgery

Department Of Urology

Department Of Neurosurgery

Division Of Surgery

The University of Texas MD Anderson Cancer Center

NoneLisly Chery is currently serving as a Neurosurgery faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Lisly Chery

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

urology oncology prostate cancer surgery surgical oncology cancer care radiation oncology bladder cancer genitourinary cancers prostatic disease kidney cancer jama oncology pharmacology metastasis outcomes research cancer imaging surgical pathology gynecologic cancers urogynecology robotics automation surgical education renal function cancer screening cohort studies cancer treatment localized prostate cancer radiological factors adherent perinephric fat active surveillance radical prostatectomy survival analysis nuclear medicine photomedicine medicinal research enzyme inhibition pharmacotherapy cancer discovery gastrointestinal surgery obesity medicine early diagnosis prognostic biomarkers biomarker (medicine) clinical radiation oncology urogenital radiology prospective cohort studies retrospective cohort studies clinical evidence therapeutic efficacy postoperative consideration treatment options cancer management geriatric urology benign prostatic hyperplasia urological research cancer risk patient-reported outcomes perioperative care general surgery cancer disparities health disparities partial nephrectomy neoadjuvant axitinib anthropometric parameters postchemotherapy surgery germ cell tumors suspected prostate cancer african american men positive biopsy phase ii trial intermediate-risk prostate cancer molecular correlates

Notable Scholarly Works

Notable Federal Grants

Collaborators

A Phase 2, Randomized, Controlled Trial of Best Systemic Therapy Versus Best Systemic Therapy With Definitive Treatment of the Primary Tumor in Metastatic Prostate Cancer. European Urology (2026)

metastasiscancer caredefinitive treatmentcancer treatmentphase 2genitourinary cancersprostate cancerprostatic diseasemedicineurologyprimary tumorpharmacotherapyclinical trialsoncology

Low Testosterone Levels and Grade Group Progression Among Localized Prostate Cancer Patients on Active Surveillance: A Retrospective Cohort Study. The Journal of Urology (2026)

active surveillanceradiation oncologylow testosterone levelscancer screeninggenitourinary cancersprostate cancerprostatic diseasejama oncologygrade group progressionurologycancer careoncology

Glp-1 Agonist Use Among Men With Localized Prostate Cancer: A Narrative Review and Rationale for Prospective Clinical Trials. Urology (2025)

Andrew FangDaniel E FrigoAndrew HahnZayd RazoukiJessica HwangEfstratios KoutroumpakisTarek LawenMatthew SmithJill Hamilton-ReevesJohn DiGiovanniNoel HiggasonRebekka S GarciaBrian F ChapinCurtis PettawayLisly CheryPatricia TroncosoChristopher LogothetisCarrie R DanielPeng WeiJustin R Gregg

prospective cohort studiesepidemiologygliomasimmunologysurgical oncologypharmacologytherapeutic targetsretrospective cohort studiestumor biologylocalized prostate cancerphotomedicinemedicinal researchprospective clinical trialsclinical evidencenarrative reviewcohort studiesoncologymolecular medicinecancer imagingenzyme inhibitiontherapeutic efficacy

Grade Group 1 Core Volume at Time of Biopsy is Not Associated With Rate of Adverse Pathology at Radical Prostatectomy. JU Open Plus (2025)

radiation oncologyradical prostatectomysurgical oncologysurgical pathologyprostate cancergenitourinary cancersprostatic diseasecore volumegrade group 1urologycancer careoncology

The Intersection of Race and Adiposity in Prostate Cancer: A Narrative Review. European Journal of Cancer Prevention (2025)

narrative reviewobesity medicinecancer carehealth equityoncologyracial discriminationsocial determinants of healthprostate cancercancer disparitiesafrican american studieshealth disparitiesurologyhealth sciencesobesityrace

A Phase II Trial of Apalutamide for Intermediate‐Risk Prostate Cancer and Molecular Correlates. British Journal of Urology (2024)

Andrew W. HahnGaniraju C. ManyamBrian F. ChapinMiao ZhangYao YuCurtis A. PettawayLisly CheryLouis L. PistersJohn F. WardJustin R. GreggJohn PapadopoulosAshish M. KamatMarisa LozanoAnh HoangBradley BroomXuemei WangChad D. HuffChristopher J. LogothetisPatricia TroncosoPatrick G. PiliéJohn W. Davis

neurologyprostate cancerpharmacologyphase ii trialintermediate-risk prostate cancerurologymolecular correlatesclinical trialsoncology

A West African Ancestry‐Associated Snp on 8Q24 Predicts a Positive Biopsy in African American Men With Suspected Prostate Cancer Following Psa Screening. The Prostate (2024)

Jian GuLisly CheryGraciela M. Nogueras GonzálezChad HuffSara StromJeffrey A. JonesDonald P. GriffithSteven E. CanfieldXuemei WangXuelin HuangPamela RobersonQing H. MengPatricia TroncosoMichael IttmannMichael CovinskyMichael ScheurerMargarita Irizarry RamirezCurtis A. Pettaway

early diagnosiscancer screeningsuspected prostate cancerprostate cancerafrican american studiesafrican american menurologypositive biopsy

Correction to: Surgical Management and Considerations for Patients With Localized High-Risk Prostate Cancer. Current Treatment Options in Oncology (2024)

Andrew M. FangJamaal JacksonJustin R. GreggLisly CheryChad TangDevaki Shilpa SurasiBilal A. SiddiquiSoroush Rais-BahramiTharakeswara BathalaBrian F. Chapin

postoperative considerationsurgical managementsurgeryprostate cancertreatment optionscancer treatmentcancer managementoncology

The Association of Body Mass Index With Tumor Aggression Among Men Undergoing Radical Prostatectomy. Urologic Oncology Seminars and Original Investigations (2024)

Justin R. GreggResa MagillAndrew M. FangBrian F. ChapinJohn W. DavisMehrad AdibiLisly ChéryJohn PapadopoulosCurtis PettawayLouis PistersJohn F. WardAndrew W. HahnCarrie R. DanielJerusha BhaskaranKeyi ZhuMireya GuerreroMiao ZhangPatricia Troncoso

radical prostatectomysurgerybody mass indexprostate cancerurologytumor aggression

Validation of a Prognostic Blood-Based Sphingolipid Panel for Men With Localized Prostate Cancer Followed on Active Surveillance. Biomarker Research (2024)

Justin R. GreggLisa NewcombRanran WuJennifer DennisonJohn W. DavisCurtis PettawayLouis PistersJohn F. WardBrian F. ChapinLisly ChéryAhmet UrkmezAndrew M. FangNoel HiggasonPatricia TroncosoCarrie R. DanielChristopher LogothetisTimothy C. ThompsonAndrew W. HahnMenghan LiuYingye ZhengDan W. LinSamir HanashEhsan IrajizadJohannes Fahrmann

active surveillanceprognostic biomarkersprostate cancercancer researchlocalized prostate cancerbiomarkersurologybiomarker (medicine)

1
2
3
10 / page

Lisly Chery

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Palliative, Rehabilitation And Integrative Medicine

Department Of Neurosurgery

Division Of Surgery

Department Of Urology

Department Of Neurosurgery

Division Of Surgery

The University of Texas MD Anderson Cancer Center

NoneLisly Chery is currently serving as a Neurosurgery faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Lisly Chery

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

A Phase 2, Randomized, Controlled Trial of Best Systemic Therapy Versus Best Systemic Therapy With Definitive Treatment of the Primary Tumor in Metastatic Prostate Cancer. European Urology (2026)

metastasiscancer caredefinitive treatmentcancer treatmentphase 2genitourinary cancersprostate cancerprostatic diseasemedicineurologyprimary tumorpharmacotherapyclinical trialsoncology

Low Testosterone Levels and Grade Group Progression Among Localized Prostate Cancer Patients on Active Surveillance: A Retrospective Cohort Study. The Journal of Urology (2026)

active surveillanceradiation oncologylow testosterone levelscancer screeninggenitourinary cancersprostate cancerprostatic diseasejama oncologygrade group progressionurologycancer careoncology

Glp-1 Agonist Use Among Men With Localized Prostate Cancer: A Narrative Review and Rationale for Prospective Clinical Trials. Urology (2025)

Grade Group 1 Core Volume at Time of Biopsy is Not Associated With Rate of Adverse Pathology at Radical Prostatectomy. JU Open Plus (2025)

radiation oncologyradical prostatectomysurgical oncologysurgical pathologyprostate cancergenitourinary cancersprostatic diseasecore volumegrade group 1urologycancer careoncology

The Intersection of Race and Adiposity in Prostate Cancer: A Narrative Review. European Journal of Cancer Prevention (2025)

A Phase II Trial of Apalutamide for Intermediate‐Risk Prostate Cancer and Molecular Correlates. British Journal of Urology (2024)

neurologyprostate cancerpharmacologyphase ii trialintermediate-risk prostate cancerurologymolecular correlatesclinical trialsoncology

A West African Ancestry‐Associated Snp on 8Q24 Predicts a Positive Biopsy in African American Men With Suspected Prostate Cancer Following Psa Screening. The Prostate (2024)

early diagnosiscancer screeningsuspected prostate cancerprostate cancerafrican american studiesafrican american menurologypositive biopsy

Correction to: Surgical Management and Considerations for Patients With Localized High-Risk Prostate Cancer. Current Treatment Options in Oncology (2024)

Andrew M. FangJamaal JacksonJustin R. GreggLisly CheryChad TangDevaki Shilpa SurasiBilal A. SiddiquiSoroush Rais-BahramiTharakeswara BathalaBrian F. Chapin

postoperative considerationsurgical managementsurgeryprostate cancertreatment optionscancer treatmentcancer managementoncology

The Association of Body Mass Index With Tumor Aggression Among Men Undergoing Radical Prostatectomy. Urologic Oncology Seminars and Original Investigations (2024)

radical prostatectomysurgerybody mass indexprostate cancerurologytumor aggression

Validation of a Prognostic Blood-Based Sphingolipid Panel for Men With Localized Prostate Cancer Followed on Active Surveillance. Biomarker Research (2024)

active surveillanceprognostic biomarkersprostate cancercancer researchlocalized prostate cancerbiomarkersurologybiomarker (medicine)

1
2
3
10 / page